TrialCancer immunology, immunotherapy : CII2024

Impaired TGF-β signaling via AHNAK family mutations elicits an esophageal cancer subtype with sensitivities to genotoxic therapy and immunotherapy.

Zihang Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.